Easy-to-digest carbohydrates
Phase 2 Data: The Evidence That Set Expectations The Phase 2 trial of retatrutide in adults with obesity, published in The New England Journal of Medicine in 2023, enrolled 338 participants across multiple dose cohorts and a placebo arm over 48 weeks [1]
Rapid injection forces medication into tissue faster than it can disperse, creating pressure that feels like a burning sting
Two additional endpoints are worth noting
A vanity effect in how respondents present themselves may explain why Gallups obesity estimates are typically somewhat lower than those obtained from studies that use randomized clinical measurements of height and weight
The solution, for the most part, is to strengthen our meal pattern, fueling our body more regularly and consistently, but without grazing